[Post-traumatic stress disorder in general practice: comparing efficacy of pharmacological and non-pharmacological therapies] [0.03%]
创伤后应激障碍的药物与非药物治疗效果分析
Viviana Forte,David Slawson
Viviana Forte
[Value-Based Healthcare analysis of antibiotic administration in non-hospital settings: assessment of patient benefits and economic sustainability of the system] [0.03%]
基于价值的医疗抗菌药物使用的非医院场所管理分析：评估患者获益和系统的经济效益可持续性
Leonardo Gianluca Lacerenza,Bruno Sposato,Cinzia Garofalo et al.
Leonardo Gianluca Lacerenza et al.
Introduction: Healthcare-associated infections (HAIs) represent a significant health and economic problem, with high frequency and severity. The project aims to analyse the existing organisational model in order to maximi...
Comparative Study
Recenti progressi in medicina. 2026 Mar;117(3):137-145. DOI:10.1701/4669.46828 2026
[Pharmacovigilance and antibiotic resistance: analysis of real-world data from the Rizzoli Orthopedic Institute in the management of antibiotic-related adverse drug reactions in musculoskeletal diseases] [0.03%]
[药物警戒与抗生素耐药性：真实世界数据在肌肉骨骼疾病抗菌药物不良反应管理中的分析——从里佐利骨科医院的案例谈起]
Daniela D&#x;Alonzo,Laura Trombetta,Federica Matino et al.
Daniela D&#x;Alonzo et al.
Background: Antibiotics can cause adverse drug reactions (ADRs) and hypersensitivity reactions (HSRs) through a variety of mechanisms. At our hospital, patients admitted with musculoskeletal tissue infection are followed ...
Massimo Sartelli,Francesco M Labricciosa
Massimo Sartelli
Healthcare-associated infections (HAIs) are infections that occur during hospitalization or healthcare treatment, representing a major public health threat. They have serious consequences: clinical (deterioration of conditions, increased mo...
[End-stage skin failure: an evolving clinical paradigm between wound care and palliative care] [0.03%]
[终末期皮肤损伤：伤口护理和舒缓护理临床实践的演变]
Greta Ghizzardi,Rita Marson,Valentina Vanzi et al.
Greta Ghizzardi et al.
Over the past decade, the concept of skin failure has received increasing international attention, including definitions such as terminal ulcers, Skin Changes at Life's End (SCALE), and unavoidable pressure injuries. In the absence of a sha...
Fabrizio Consorti
Fabrizio Consorti
Medicine today faces a crisis rooted in several factors: increased social complexity, evolving patient expectations, and the need to move beyond purely technical and standardized models. The article discusses the importance of restoring the...
[Successfully second line treatment with selinexor-bortezomib-dexamethasone of a patient affected by multiple myeloma, refractory to first line therapy with daratumab-lenalidomide-dexamethasone] [0.03%]
一位接受达雷妥尤单抗-来那度胺-地塞米松一线治疗后复发的多发性骨髓瘤患者成功采用_selinexor-硼替佐米-地塞米松二线治疗案例报告
Laura Paris
Laura Paris
Refractoriness to first-line therapy with daratumumab and lenalidomide represents the paradigm of patients with functional high-risk multiple myeloma. In Italy, the currently available second-line therapies have been approved based on phase...
[Early use of selinexor-bortezomib-dexamethasone after anti-CD38-based therapy in multiple myeloma: a case report] [0.03%]
塞利尤索夫-硼替佐米-地塞米松治疗基于抗CD38疗法的多发性骨髓瘤的早期应用：病例报告
Antonia Cagnetta,Matteo Garibotto
Antonia Cagnetta
In transplant-ineligible patients with multiple myeloma (MM), disease relapse represents a critical step in the therapeutic pathway. The increasingly early use of frontline regimens containing anti-CD38 monoclonal antibodies has led to sign...
[Deep and durable response with the selinexor-bortezomib-dexamethasone combination in a patient with multiple myeloma refractory to first-line treatment] [0.03%]
塞利尼索-硼替佐米地塞米松联合方案治疗初治复发难治多发性骨髓瘤患者的深度有效反应案例报告
Roberta Della Pepa
Roberta Della Pepa
The management of relapsed or refractory multiple myeloma in elderly patients remains challenging, particularly in cases of early refractoriness to first-line anti-CD38-based regimens, which is associated with poor prognosis and limited the...